⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SLNO News
Soleno Therapeutics, Inc. Common Stock
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Drug Risks: Levi & Korsinsky
globenewswire.com
SLNO
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO)
prnewswire.com
SLNO
Soleno Therapeutics, Inc. (SLNO) Class Action Lawsuit: Investors Face May 5, 2026, Deadline
globenewswire.com
SLNO
Bronstein, Gewirtz & Grossman LLC Urges Soleno Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
SLNO
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
SLNO
Shareholder Alert: The Ademi Firm investigates whether Soleno Therapeutics Inc.'s Transaction with Neurocrine is Fair to Public Shareholders
prnewswire.com
SLNO
SLNO Stock Alert: Halper Sadeh LLC is Investigating Whether Soleno Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
SLNO
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
globenewswire.com
SLNO
Form 8-K
sec.gov
SLNO
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
prnewswire.com
SLNO
NBIX